Objective: To define the clinical spectrum and etiology of progressive myoclonic epilepsies (PMEs) in Italy using a database developed by the Genetics Commission of the Italian League against Epilepsy
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...
Progressive Myoclonus Epilepsies (PMEs) are a group of uncommon clinically and genetically heterogen...
7 páginas, 2 tablas, 1 figuraProgressive myoclonus epilepsies (PMEs) are a group of genetic neurolog...
Objective: To define the clinical spectrum and etiology of progressive myoclonic epilepsies (PMEs) i...
Objective:To define the clinical spectrum and etiology of progressive myoclonic epilepsies (PMEs) in...
Progressive myoclonic epilepsies (PMEs) are a group of rare disorders characterized by the occurrenc...
Purpose: Progressive myoclonus epilepsies (PMEs) result from several genetic disorders. Few informat...
Progressive myoclonic epilepsies (PME) are a group of rare disorders characterized by the occurrence...
The progressive myoclonic epilepsies (PMEs) are a group of symptomatic generalized epilepsies caused...
The history of the progressive myoclonus epilepsies (PMEs) spans more than a century. However, the r...
Progressive myoclonic epilepsies are a group of disorders characterised by a relentlessly progressiv...
The authors report the clinical criteria for the diagnosis of progressive myoclonus epilepsies on th...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
Objective To investigate the features of clinical phenotype and gene mutation of progressive myoclon...
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...
Progressive Myoclonus Epilepsies (PMEs) are a group of uncommon clinically and genetically heterogen...
7 páginas, 2 tablas, 1 figuraProgressive myoclonus epilepsies (PMEs) are a group of genetic neurolog...
Objective: To define the clinical spectrum and etiology of progressive myoclonic epilepsies (PMEs) i...
Objective:To define the clinical spectrum and etiology of progressive myoclonic epilepsies (PMEs) in...
Progressive myoclonic epilepsies (PMEs) are a group of rare disorders characterized by the occurrenc...
Purpose: Progressive myoclonus epilepsies (PMEs) result from several genetic disorders. Few informat...
Progressive myoclonic epilepsies (PME) are a group of rare disorders characterized by the occurrence...
The progressive myoclonic epilepsies (PMEs) are a group of symptomatic generalized epilepsies caused...
The history of the progressive myoclonus epilepsies (PMEs) spans more than a century. However, the r...
Progressive myoclonic epilepsies are a group of disorders characterised by a relentlessly progressiv...
The authors report the clinical criteria for the diagnosis of progressive myoclonus epilepsies on th...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
Background and Objectives To assess the current diagnostic yield of genetic testing for the progress...
Objective To investigate the features of clinical phenotype and gene mutation of progressive myoclon...
Electroclinical, morphological, biochemical and molecular genetic data from 17 patients affected by ...
Progressive Myoclonus Epilepsies (PMEs) are a group of uncommon clinically and genetically heterogen...
7 páginas, 2 tablas, 1 figuraProgressive myoclonus epilepsies (PMEs) are a group of genetic neurolog...